Real-world (RW) treatment (Tx) patterns and clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC): Results of a nationwide, longitudinal, retrospective study in Hungary

被引：0
作者：
Maraz, A. C. [1 ]
Nagy, B. [2 ]
Macher, T. [2 ]
Jesko, J. [2 ]
Tischler, E. [3 ]
Csongvai, C. [4 ]
Kearney, M. [5 ]
机构：
[1] Univ Szeged, Dept Oncotherapy, Szeged, Hungary
[2] Healthware Consulting Ltd, Budapest, Hungary
[3] Merck Kft, Market Access, Budapest, Hungary
[4] Merck Kft, Med Affairs, Budapest, Hungary
[5] Merck Healthcare KGaA, Global Evidence & Value Dev, Darmstadt, Germany
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1834
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1756P
引用
收藏
页码：S1341 / S1341
页数：1
相关论文
共 50 条
  • [41] Real-world treatment patterns and outcomes in patients with metastatic melanoma
    Dokanovic, Dejan
    Lazic, Bojana
    Gojkovic, Zdenka
    Cvijetic, Zeljka
    Sokolovic, Emir
    Ceric, Timur
    Jungic, Sasa
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2023, 151 (3-4) : 209 - 215
  • [42] Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US
    Shore, N.
    Laliberte, F.
    Ionescu-Ittu, R.
    Gayle, A.
    Amin, S.
    Yang, L.
    Payne, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S534 - S535
  • [43] Real-world treatment patterns and sequencing in patients with locally advanced or metastatic urothelial cancer (la/mUC) in the US.
    Kearney, Mairead
    Mahmoudpour, Hamid
    Ike, Chiemeka
    Modh, Ambar
    Monzon, Sebastian
    Fragkogianni, Matina
    Carson, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [44] Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study
    Deng, Ting
    Duan, Jingjing
    Bai, Ming
    Zhang, Le
    Li, Hongli
    Liu, Rui
    Ning, Tao
    Ge, Shaohua
    Wang, Xia
    Yang, Yuchong
    Ji, Zhi
    Wang, Feixue
    Ba, Yi
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2023, 14
  • [45] Erdafitinib treatment in Brazilian patients with metastatic urothelial carcinoma (mUC): real-world evidence from an Expanded Access Program
    Monteiro, Fernando Sabino M.
    e Silva, Adriano Goncalves
    Gomes, Andrea Juliana P. de S.
    Dutra, Carolina
    Ferreira, Naira Oliveira
    Mariano, Rodrigo Coutinho
    Schutz, Fabio A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [46] Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan
    Ishihara, Hiroki
    Takagi, Toshio
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (05) : 559 - 560
  • [47] Real-World Treatment Patterns and Clinical Outcomes in Advanced/Metastatic NSCLC Patients in England
    Verleger, Katharina
    Hertel, Nadine
    Solem, Caitlyn
    Penrod, John R.
    Macahilig, Cynthia
    Luo, Linlin
    Crawford, S. Michael
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 5 - 5
  • [48] Treatment patterns and overall survival in metastatic urothelial carcinoma in a real-world, US setting
    Simeone, Jason C.
    Nordstrom, Beth L.
    Patel, Ketan
    Mann, Helen
    Klein, Alyssa B.
    Horne, Laura
    CANCER EPIDEMIOLOGY, 2019, 60 : 121 - 127
  • [49] Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era
    Shah, Neil J.
    Sura, Sneha D.
    Shinde, Reshma
    Shi, Junxin
    Singhal, Puneet K.
    Robert, Nicholas J.
    Vogelzang, Nicholas J.
    Perini, Rodolfo F.
    Motzer, Robert J.
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 49 : 110 - 118
  • [50] Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility
    Morgans, Alicia K.
    Galsky, Matthew D.
    Wright, Phoebe
    Hepp, Zsolt
    Chang, Nancy
    Willmon, Candice L.
    Sesterhenn, Steve
    Liu, Yutong
    Sonpavde, Guru P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) : 357e11 - 357e21
12345